MedTrace Logo

Factor XIII in Major Burns Coagulation

NCT03188913 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2017-06-16

No results posted yet for this study

Summary

Prospective observational study in which FXIII levels and coagulation tests and cicatrization are measured during the 30 days after the thermal trauma.

Conditions

  • Burns
  • Coagulation Disorder
  • Factor XIII Deficiency
  • Cicatrization
  • Endothelial Dysfunction

Interventions

DIAGNOSTIC_TEST

Coagulation tests

The following plasma values will be measured: prothrombin time, activated partial thromboplastin time, thrombin time, functional fibrinogen, lactate, base excess, fibrin monomers, Factor XIII, Factor XII, Factor VIII, Fact von Willebrand, Plasmin, Plasminogen, Alpha-2-antiplasmin, antithrombin, protein C, Heparan sulfate, synecan 1. Surveys on the state of healing and moisture titration will be performed using Tewamether

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Patricia Guilabert, MD · Vall d'Hebron Universitary Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-19
Primary Completion
2019-06-19
Completion
2019-07-21

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03188913 on ClinicalTrials.gov